NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells

Author：                

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|6|2586-2590

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.6, 2015-01, pp. : 2586-2590

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p62 participates in the inhibition of NF-κB signaling and apoptosis induced by sulfasalazine in human glioma U251 cells

By                

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 235-243

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-κB/Bcl2 pathway

By  

Molecular Medicine Reports, Vol. 11, Iss. 3, 2015-01 ,pp. : 1951-1955

Spandidos Publications

Access to resources Recommend Favorite

Extract of Bryophyllum laetivirens reverses etoposide resistance in human lung A549 cancer cells by downregulation of NF-κB

By                  

Oncology Reports, Vol. 31, Iss. 1, 2014-01 ,pp. : 161-168

Spandidos Publications

Access to resources Recommend Favorite

Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway

By        

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 2050-2056

Spandidos Publications

Access to resources Recommend Favorite

Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells

By        

Oncology Reports, Vol. 28, Iss. 4, 2012-01 ,pp. : 1176-1180

Spandidos Publications

Access to resources Recommend Favorite